Website: http://biovista.com/

Biovista is a pioneer of systematic drug repositioning Biovista applies a systematic discovery platform to develop a pipeline of repositioned drug candidates in neurodegenerative diseases, epilepsy, oncology and orphan diseases. Biovista scientists use its technology platform to analyze massive data resources and identify non-obvious, mechanism-of-action based associations between compounds, molecular targets and disease. We use this insight to find new uses for existing drugs or drug combinations, assess their risk profile and advance them to PoC and Clinical Phase IIa/b sooner, cheaper and with a higher probability of success than has been possible to date.